Chelating agents bind lead in soft tissues and are used in the treatment of lead poisoning to enhance urinary and biliary excretion of lead, thus decreasing total lead levels in the body (1). During the past 30 years, environmental and dietary exposures to lead have decreased substantially, resulting in a considerable decrease in population blood [...]
Read the full article...
1
Completed
Combination Iron Chelation Therapy
Conditions:
Iron Overload; Thalassemia
Intervention:
Drug: Combination Iron Chelation Therapy
2
Completed
Long-Term Lead Chelation Therapy and Progressive Renal Insufficiency
Condition:
Urologic Disease
Intervention:
Drug: calcium disodium EDTA (edetate calcium disodium)
3
Active, not recruiting
Penicillamine Chelation for Children With Lead Poisoning
Conditions:
Lead Poisoning; Vitamin D Deficiency
Interventions:
Device: d-penicillamine; Drug: placebo
4
Active, not recruiting
An Extension Study of Iron Chelation Therapy With Deferasirox in β-Thalassemia Patients With Transfusional Iron Overload
Condition:
Transfusional Iron Overload in β-Thalassemia
Intervention:
Drug: Deferasirox
5
Active, not recruiting
Mercury Chelation to Treat Autism
Conditions:
Autism; [...]
Read the full article...
